Ophthalmology Times1d
Part 4: Biggest innovations in ophthalmology in 50 years
In celebration of Ophthalmology Times 50th anniversary, we asked leading experts in the field what they see as the biggest ...
Ophthalmology Times1d
Doctors warn TikTok & Instagram reels may be damaging eyes long-term
Recent estimates show that there are over 2 billion users on Instagram, of which over 726.8 million interact with reels on ...
Ophthalmology Times1d
Avisi Technologies releases 6-month interim results from VITA trial
The trial is designed to assess the safety and effectiveness of Avisi Technologies' investigational VisiPlate device in ...
Ophthalmology Times2d
FDA issues Complete Response Letter to Aldeyra Therapeutics for resubmitted New Drug Application of reproxalap
The company stated that the FDA noted at least one additional adequate and well controlled study to demonstrate a positive ...
Ophthalmology Times3d
NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
Andrew G. Lee, MD, and Drew Carey, MD, return for this episode of 'NeuroOp Guru' to discuss how sixth nerve palsy with ...
Ophthalmology Times4d
Setting the stage in LA: Neda Shamie, MD, on the 19th Annual Controversies in Modern Eye Care
The May 4 event, themed around Star Wars, will feature the latest innovations, foster open discussions, and provide a ...
Ophthalmology Times4d
Zeiss Medical Technology gains NMPA approval for ILM-Blue in China
The approval makes ILM-Blue the first DORC posterior dye product available in China, according to a press release from Zeiss.
Ophthalmology Times4d
Prevent Blindness declares April as Women’s Eye Health and Safety Month
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...